Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Feb 17, 2009

Premium

Richard Rava has joined Artemis Health as senior vice president of research and development, a new position at the firm. Rava comes to Artemis from Affymetrix, where he was a scientific co-founder and most recently senior vice president of research and development.


Joseph Blanchard will take over as chief operating officer at Aushon Biosystems. Blanchard previously was senior vice president of business development and strategy at Decision Biomarkers, and he has spent over 20 years in the life sciences field, Aushon said last week.


Agendia has tapped Alan Carter to serve as its new vice president of global business development. Carter formerly served as an executive at BioTrove, Celera, Applied Biosystems, and PerkinElmer. At Agendia, Carter will handle strategic business opportunities for the company's molecular diagnostics portfolio.


RainDance Technologies has named Patrick Kelly to the newly created position of European sales director. Kelly, based in Manchester, UK, joins the firm from Helicos Biosciences where he was global business manager for the company's European operations. He has also held European sales positions for Agilent Technologies, Affymetrix, and Applied Biosystems.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.